-
Scientists are looking at the ways humans change the planet-- and the impact that has on the spread of infectious disease. You might be surprised at some of their conclusions.
-
When Amylyx Pharmaceuticals found out its ALS drug Relyvrio didn't work, the company took the unusual step of voluntarily pulling it off the market.
-
Michael Sanchez was testing out his new camera when he happened upon a feathered subject. The blue rock-thrush he photographed on the coast of northern Oregon last week has excited the birding world.
-
Federal health officials say the U.S. has the building blocks to make a vaccine to protect humans from bird flu, if needed. But experts warn we're nowhere near prepared for another pandemic.
-
NPR's Juana Summers talks with Regina Barber and Emily Kwong of Short Wave about biodegradable plastic, simulating growing crops on Mars, and how deer are disrupting caribou populations.
-
The health officials say the country is ready to produce a vaccine against a worrisome flu virus that recently jumped from birds to cows and at least one person. But some experts are skeptical.
-
Women under 60 can benefit from hormone therapy to treat hot flashes and other symptoms of menopause. That's according to a new study, and is a departure from what women were told in the past.
-
The time a person has to decide whether to have an abortion in Florida and other states with six-week abortion bans is at most two weeks. Why? It's has to do with how we date early pregnancy.
-
Some birds kill their siblings soon after hatching. Other birds spend their whole lives with their siblings and will even risk their lives to help each other.
-
A rise in breast cancer among younger women prompted the U.S. Preventive Task Force to issue new screening guidelines. They recommend mammograms every other year, starting at age 40.
-
An economic perspective on misinformation
-
A therapy that restores brain cells impaired by a rare genetic disorder may offer a strategy for treating conditions like autism, epilepsy, and schizophrenia.